← FDA Drug Approvals (Drugs@FDA)
ADMELOG
BLA · Biologics License Application · Sponsor: SANOFI-AVENTIS US · Approved 2017-12-11
Drug application
- FDA Application #
BLA209196- Application type
- Biologics License Application
- Brand name
- ADMELOG
- Generic name
- INSULIN LISPRO
- Active ingredients
- INSULIN LISPRO
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- SANOFI-AVENTIS US
- Manufacturer
- Sanofi-Aventis U.S. LLC
- First approval
- 2017-12-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown